Merck (MRK) has received approval from the European Commission for a subcutaneous injectable version of Keytruda ...
Zacks Investment Research on MSN
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback